ASP Isotopes Inc. (ASPI) is a specialized company focusing on the production and commercialization of isotopes for medical, industrial, and scientific applications. Isotopes are critical elements with unique atomic structures used in various fields, from cancer treatment and diagnostic imaging in healthcare to advanced research and environmental monitoring. ASP Isotopes leverages cutting-edge technology to produce […]
Read MoreFeatured Content Nurix Therapeutics, Inc. (NRIX) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer and other serious diseases by harnessing the power of the ubiquitin-proteasome system. Founded in 2015 and headquartered in San Francisco, California, Nurix aims to advance the field of targeted protein degradation, a cutting-edge approach that allows for […]
Read MoreFeatured Content Delcath Systems, Inc. (DCTH) is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of cancer. Founded in 1988, Delcath specializes in regional chemotherapy systems that deliver high doses of chemotherapy directly to tumors while minimizing systemic exposure and side effects. The company’s flagship product, the Delcath Hepatic Delivery […]
Read MoreJasper Therapeutics, Inc. (JSPR) Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. Nkarta, Inc. (NKTX) Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Perspective Therapeutics, Inc. (CATX) Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha […]
Read MorePerspective Therapeutics, Inc. is a clinical-stage radiopharmaceutical company focused on developing advanced treatments for cancer. The company leverages its proprietary technology, which utilizes the alpha-emitting isotope Pb-212, to deliver targeted radiation directly to cancer cells through specialized peptides. This precision-targeted approach aims to minimize damage to surrounding healthy tissues while effectively treating cancerous cells. One […]
Read MoreJanux Therapeutics, Inc. (JANX) is a biotechnology company focused on developing next-generation immunotherapies for cancer treatment. Their proprietary platform, Tumor Activated T Cell Engager (TRACTr), is designed to create highly effective and targeted cancer therapies that minimize side effects. Janux’s innovative approach harnesses the power of the immune system to selectively target and eliminate cancer […]
Read MoreTscan Therapeutics Inc (TCRX) is a biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell therapies for the treatment of cancer. The company’s proprietary platform identifies novel TCR targets and engineers TCRs directed against these targets for use in TCR-T cell therapies. These therapies aim to harness the power of the […]
Read MoreCardiff Oncology Inc. (CRDF) is a clinical-stage biotechnology company focused on developing novel treatments for cancer. The company’s primary objective is to leverage its expertise in oncology and drug development to create therapies that can address unmet medical needs and improve the lives of patients battling cancer. Three main drivers of growth for Cardiff Oncology […]
Read MoreJanux Therapeutics Inc (JANX) is a biopharmaceutical company focused on developing innovative cancer immunotherapies. The company aims to harness the power of the immune system to target and eliminate cancer cells. Their approach involves creating novel therapeutics that can stimulate the body’s immune response against tumors, potentially leading to improved outcomes for patients with various […]
Read MoreVerastem, Inc. (VSTM) is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for the treatment of cancer. The company was founded in 2010 and is headquartered in Needham, Massachusetts. Verastem’s mission is to improve the lives of patients suffering from cancer by targeting the underlying biology of cancer stem cells, […]
Read MoreNkarta Inc (NKTS) is a biotechnology company focused on the research, development, and commercialization of natural killer (NK) cell therapies for the treatment of cancer. NK cells are a type of immune cell that can identify and destroy cancerous or infected cells in the body. Nkarta’s innovative approach involves harnessing and enhancing the innate power […]
Read MoreImmunome, Inc. (IMNM) is a biopharmaceutical company primarily engaged in discovering and developing antibody therapeutics. The company focuses on treatments for oncology and infectious diseases. Its lead oncology program is IMM-ONC-01, which targets IL-38, a tumor-derived immune checkpoint that helps tumors evade the immune system. Additionally, Immunome is developing IMM-BCP-01, an antibody cocktail aimed at […]
Read MoreFingerMotion, Inc. (FNGR) FingerMotion, Inc., a mobile data specialist company, provides mobile payment and recharge platform system in China. Nuvalent, Inc. (NUVL) Nuvalent, Inc., a clinical stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Immunovant, Inc. (IMVT) Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of […]
Read MoreNo matter how much the world moves away from COVID-19, the truth is that it isn’t going away. The move by government entities as well as healthcare organizations around the world to “endemic” phase protocols doesn’t mean the disease has been eradicated. It really means that the disease is acknowledged as a permanent part of […]
Read MoreOncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. ONCY $1.7400 0.1300 % 8.0700 Oncolytics Biotech Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 8.07% Wk: 7.41% Mo: 48.72% Yrly: 55.36% […]
Read More